Personalized medicine

February 12, 2020
crowd of women

Trial Results: New TAILORx data shows chemotherapy benefit for women at high risk of breast cancer recurrence

The TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.
September 20, 2021
Doctor and patient talking over laptop

Ongoing Trial: The INDICATE trial is testing ways to personalize treatment for men with prostate cancer that returns after surgery

The study will assess if PET/CT scans can help identify patients who may have better outcomes from adding customized therapy to standard-of-care treatment
September 20, 2021
Patient and doctor talking over clipboard

Now Enrolling: The APOLLO clinical trial is studying an additional treatment option after standard therapy for certain patients with pancreatic cancer

This study is for patients with pancreatic cancer that has been surgically removed and has a BRCA1, BRCA2, or PALB2 mutation